Spectral Medical Inc
TSX:EDT

Watchlist Manager
Spectral Medical Inc Logo
Spectral Medical Inc
TSX:EDT
Watchlist
Price: 0.495 CAD 2.06% Market Closed
Market Cap: 140m CAD
Have any thoughts about
Spectral Medical Inc?
Write Note

Spectral Medical Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Spectral Medical Inc
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Spectral Medical Inc
TSX:EDT
Accounts Receivables
CA$337k
CAGR 3-Years
-16%
CAGR 5-Years
2%
CAGR 10-Years
-6%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Accounts Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Accounts Receivables
$10.3m
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
59%
ESSA Pharma Inc
NASDAQ:EPIX
Accounts Receivables
$163k
CAGR 3-Years
-31%
CAGR 5-Years
-16%
CAGR 10-Years
5%
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Accounts Receivables
$36.5m
CAGR 3-Years
55%
CAGR 5-Years
136%
CAGR 10-Years
80%
Covalon Technologies Ltd
XTSX:COV
Accounts Receivables
CA$6.1m
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
20%
No Stocks Found

Spectral Medical Inc
Glance View

Market Cap
140m CAD
Industry
Biotechnology

Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 31 full-time employees. The firm has conducted a Phase III clinical trial for its lead product, PMX (Toraymyxin PMX-20R), which is for the treatment of patients with septic shock and endotoxemia that is measured by the Company’s Endotoxin Activity Assay (EAA). EAA and PMX are both Health Canada licensed and commercially available in Canada. The firm through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new set of platforms addressing renal replacement therapy (RRT) across the dialysis spectrum. SAMI is targeting the acute RRT market, while DIMI is targeting the chronic RRT market.

EDT Intrinsic Value
0.038 CAD
Overvaluation 92%
Intrinsic Value
Price

See Also

What is Spectral Medical Inc's Accounts Receivables?
Accounts Receivables
337k CAD

Based on the financial report for Sep 30, 2024, Spectral Medical Inc's Accounts Receivables amounts to 337k CAD.

What is Spectral Medical Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-6%

Over the last year, the Accounts Receivables growth was -53%. The average annual Accounts Receivables growth rates for Spectral Medical Inc have been -16% over the past three years , 2% over the past five years , and -6% over the past ten years .

Back to Top